{
    "Trade/Device Name(s)": [
        "VARIANT II TURBO HbA1c Kit - 2.0",
        "VARIANT II TURBO Hemoglobin-Testing System"
    ],
    "Submitter Information": "Bio-Rad Laboratories Clinical Diagnostics Group",
    "510(k) Number": "K090699",
    "Predicate Device Reference 510(k) Number(s)": [
        "K070452"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCP"
    ],
    "Summary Letter Date": "July 27, 2009",
    "Summary Letter Received Date": "June 18, 2009",
    "Submission Date": "March 12, 2009",
    "Regulation Number(s)": [
        "21CFR864.7470"
    ],
    "Regulation Name(s)": [
        "Glycosylated Hemoglobin Assay"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Hemoglobin A1c"
    ],
    "Specimen Type(s)": [
        "Whole Blood"
    ],
    "Specimen Container(s)": [
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "VARIANT II TURBO Hemoglobin-Testing System"
    ],
    "Method(s)/Technology(ies)": [
        "High Performance Liquid Chromatography (HPLC)",
        "Ion-exchange chromatography"
    ],
    "Methodologies": [
        "Chromatographic separation"
    ],
    "Submission Type(s)": [
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Bio-Rad VARIANT II TURBO HbA1c Kit - 2.0 for determination of percent hemoglobin A1c in human whole blood using ion-exchange HPLC",
    "Indications for Use Summary": "Intended for percent determination of hemoglobin A1c in human whole blood to monitor long-term glucose control in individuals with diabetes mellitus using ion-exchange high performance liquid chromatography",
    "fda_folder": "Hematology"
}